Jakubowski H, Goldman E
Department of Microbiology and Molecular Genetics, New Jersey Medical School, University of Medicine & Dentistry of New Jersey, Newark 07103.
Microbiol Rev. 1992 Sep;56(3):412-29. doi: 10.1128/mr.56.3.412-429.1992.
All living cells must conduct protein synthesis with a high degree of accuracy maintained in the transmission and flow of information from gene to finished protein product. One crucial "quality control" point in maintaining a high level of accuracy is the selectivity by which aminoacyl-tRNA synthetases furnish correctly activated amino acids, attached to tRNA species, as the building blocks for growing protein chains. During selection of amino acids, synthetases very often have to distinguish the cognate substrate from a homolog having just one fewer methyl group in its structure. The binding energy of a methyl group is estimated to contribute only a factor of 100 to the specificity of binding, yet synthetases distinguish such closely related amino acids with a discrimination factor of 10,000 to 100,000. Examples of this include methionine versus homocysteine, isoleucine versus valine, alanine versus glycine, and threonine versus serine. Many investigators have demonstrated in vitro the ability of certain aminoacyl-tRNA synthetases to edit, that is, correct or prevent incorrect attachment of amino acids to tRNA molecules. Several major editing pathways are now established from in vitro data. Further, at least some aminoacyl-tRNA synthetases have recently been shown to carry out the editing function in vivo. Editing has been demonstrated to occur in both Escherichia coli and Saccharomyces cerevisiae. Significant energy is expended by the cell for editing of misactivated amino acids, which can be reflected in the growth rate. Because of this, cellular levels of aminoacyl-tRNA synthetases, as well as amino acid biosynthetic pathways which yield competing substrates for protein synthesis, must be carefully regulated to prevent excessive editing. High-level expression of recombinant proteins imposes a strain on the biosynthetic capacity of the cell which frequently results in misincorporation of abnormal or wrong amino acids owing in part to limited editing by synthetases. Unbalanced amino acid pools associated with some genetic disorders in humans may also lead to errors in tRNA aminoacylation. The availability of X-ray crystallographic structures of some synthetases, combined with site-directed mutagenesis, allows insights into molecular details of the extraordinary selectivity of synthetases, including the editing function.
所有活细胞都必须进行蛋白质合成,且要在从基因到最终蛋白质产物的信息传递和流动过程中保持高度的准确性。维持高水平准确性的一个关键“质量控制”点是氨酰-tRNA合成酶的选择性,它能提供正确活化的氨基酸,并将其连接到tRNA种类上,作为生长中蛋白质链的构建块。在选择氨基酸的过程中,合成酶常常要将同源底物与其结构中仅少一个甲基的同系物区分开来。据估计,甲基的结合能对结合特异性的贡献仅为100倍,但合成酶能以10000至100000的区分系数区分这类密切相关的氨基酸。这方面的例子包括甲硫氨酸与高半胱氨酸、异亮氨酸与缬氨酸、丙氨酸与甘氨酸以及苏氨酸与丝氨酸。许多研究人员已在体外证明某些氨酰-tRNA合成酶具有编辑能力,也就是说,能纠正或防止氨基酸错误地连接到tRNA分子上。现在根据体外数据确定了几种主要的编辑途径。此外,最近已证明至少一些氨酰-tRNA合成酶在体内也能发挥编辑功能。已证实在大肠杆菌和酿酒酵母中都会发生编辑。细胞会消耗大量能量来编辑错误活化的氨基酸,这可能反映在生长速率上。因此,必须仔细调节细胞中氨酰-tRNA合成酶的水平以及产生蛋白质合成竞争性底物的氨基酸生物合成途径,以防止过度编辑。重组蛋白的高水平表达会给细胞的生物合成能力带来压力,这常常会导致异常或错误氨基酸的错误掺入,部分原因是合成酶的编辑作用有限。与人类某些遗传疾病相关的不平衡氨基酸库也可能导致tRNA氨基酰化错误。一些合成酶的X射线晶体学结构的可得性,结合定点诱变,有助于深入了解合成酶非凡选择性的分子细节,包括编辑功能。